Quinidine Syncope
1964; Lippincott Williams & Wilkins; Volume: 30; Issue: 1 Linguagem: Inglês
10.1161/01.cir.30.1.17
ISSN1524-4539
Autores Tópico(s)Cardiovascular Syncope and Autonomic Disorders
ResumoHomeCirculationVol. 30, No. 1Quinidine Syncope Free AccessResearch ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBQuinidine Syncope Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias ARTHUR SELZER and H. WESLEY WRAY ARTHUR SELZERARTHUR SELZER From the Cardiopulmonary Unit, Presbyterian Medical Center and the Institute of Medical Sciences, San Francisco, California. and H. WESLEY WRAYH. WESLEY WRAY From the Cardiopulmonary Unit, Presbyterian Medical Center and the Institute of Medical Sciences, San Francisco, California. Originally published1 Jul 1964https://doi.org/10.1161/01.CIR.30.1.17Circulation. 1964;30:17–26 eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Hoek L, Brouwer J, Voors A and Maass A (2023) Smart devices to measure and monitor QT intervals, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2023.1172666, 10 Foster A, Cancarevic I, Haseeb ul Rasool M, Alashry M, Ghallab M, Ahmed N, Salam S and Munira M Torsades De Pointes in a 71-Year-Old Female With Normal Qt Interval After Azithromycin Use, Cureus, 10.7759/cureus.37653 Ott W, Bellamy S, Khan M, Shahid A and Javed M Acquired Long QT Syndrome: Ventricular Fibrillation in an Otherwise Healthy Young Female, Cureus, 10.7759/cureus.37263 Do U (2023) Adverse reactions to antiarrhythmic drugs, Cardiovascular Prevention and Pharmacotherapy, 10.36011/cpp.2023.5.e1, 5:1, (1-14), Online publication date: 31-Jan-2023. Baltov B, Beyl S, Baburin I, Reinhardt J, Szkokan P, Garifulina A, Timin E, Kraushaar U, Potterat O, Hamburger M, Kügler P and Hering S (2023) Assay for evaluation of proarrhythmic effects of herbal products: Case study with 12 Evodia preparations, Toxicology Reports, 10.1016/j.toxrep.2023.04.014, 10, (589-599), . Mulla W, Murninkas M, Levi O and Etzion Y (2022) Incorrectly corrected? QT interval analysis in rats and mice, Frontiers in Physiology, 10.3389/fphys.2022.1002203, 13 Abou Warda A, Tammam M, El-Gazar R, Sarhan R and Gaber S Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges, Current Drug Safety, 10.2174/1574886316666210727152609, 17:2, (143-151) Eroglu T, Barcella C, Blom M, Mohr G, Souverein P, Torp‐Pedersen C, Folke F, Wissenberg M, de Boer A, Schwartz P, Gislason G and Tan H (2021) Out‐of‐hospital cardiac arrest and differential risk of cardiac and non‐cardiac QT‐prolonging drugs in 37 000 cases, British Journal of Clinical Pharmacology, 10.1111/bcp.15030, 88:2, (820-829), Online publication date: 1-Feb-2022. TeBay C, Hill A and Windley M (2022) Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome, Biophysical Reviews, 10.1007/s12551-022-00929-7, 14:1, (353-367), Online publication date: 1-Feb-2022. Postema P (2022) Editorial commentary: Choosing wisely: Implications of drug prescription, drug safety assessment and tools for improvement, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2020.11.009, 32:1, (50-51), Online publication date: 1-Jan-2022. Yeung C and Baranchuk A (2022) Overview of torsades de pointes Torsades de Pointes, 10.1016/B978-0-12-821446-6.00013-4, (1-26), . Woosley R (2022) Drug-induced torsades de pointes Torsades de Pointes, 10.1016/B978-0-12-821446-6.00007-9, (39-50), . Wass S and Chung M (2022) Antiarrhythmic agents and torsades de pointes Torsades de Pointes, 10.1016/B978-0-12-821446-6.00005-5, (183-211), . Krantz M and Haigney M (2022) Methadone, synthetic opioids and torsades de pointes Torsades de Pointes, 10.1016/B978-0-12-821446-6.00004-3, (267-284), . Heijman J and Dobrev D (2022) Arrhythmias Comprehensive Pharmacology, 10.1016/B978-0-12-820472-6.00082-7, (432-468), . Burashnikov A, Barajas-Martinez H, Cox R, Demitrack M, Fossler M, Kramer M, Kleiman R, Kowey P and Antzelevitch C (2021) Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk, Heart Rhythm, 10.1016/j.hrthm.2021.08.028, 18:12, (2177-2186), Online publication date: 1-Dec-2021. Li D, Cox Z, Richardson T, Kanagasundram A, Saavedra P, Shen S, Montgomery J, Murray K, Roden D and Stevenson W (2021) Quinidine in the Management of Recurrent Ventricular Arrhythmias, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2021.03.024, 7:10, (1254-1263), Online publication date: 1-Oct-2021. Chan X, Haeusler I, Win Y, Pike J, Hanboonkunupakarn B, Hanafiah M, Lee S, Djimdé A, Fanello C, Kiechel J, Lacerda M, Ogutu B, Onyamboko M, Siqueira A, Ashley E, Taylor W, White N and Beeson J (2021) The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis, PLOS Medicine, 10.1371/journal.pmed.1003766, 18:9, (e1003766) Hanayneh S, Panna M, Miles W and Goel R (2021) Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-021-00940-3, 23:9, Online publication date: 1-Sep-2021. Desmarais J and Link M (2021) Hydroxychloroquine: Not a Heart Breaker!, Arthritis Care & Research, 10.1002/acr.24493, 73:6, (770-771), Online publication date: 1-Jun-2021. Campana C, Dariolli R, Boutjdir M and Sobie E (2021) Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development, Frontiers in Pharmacology, 10.3389/fphar.2021.598549, 12 Heijman J, Hohnloser S and Camm A (2021) Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future, EP Europace, 10.1093/europace/euaa426, 23:Supplement_2, (ii14-ii22), Online publication date: 10-Apr-2021. Alahmadi A, Davies A, Royle J, Goodwin L, Cresswell K, Arain Z, Vigo M and Jay C (2021) An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology, Computers in Biology and Medicine, 10.1016/j.compbiomed.2021.104281, 131, (104281), Online publication date: 1-Apr-2021. Eftekhar S, Kazemi S, Barary M, Javanian M, Ebrahimpour S, Ziaei N and Tomlinson B (2021) Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients, Cardiovascular Therapeutics, 10.1155/2021/6683098, 2021, (1-7), Online publication date: 27-Feb-2021. Trinkley K, Pell J, Martinez D, Maude N, Hale G and Rosenberg M (2021) Assessing Prescriber Behavior with a Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome, Applied Clinical Informatics, 10.1055/s-0041-1724043, 12:01, (190-197), Online publication date: 1-Jan-2021. Su S, Sun J, Wang Y and Xu Y (2021) Cardiac hERG K+ Channel as Safety and Pharmacological Target Pharmacology of Potassium Channels, 10.1007/164_2021_455, (139-166), . Golovina G, Zaphiraki K and Kosmacheva E (2020) Drug-induced long qt syndrome, Arrhythmology, 10.35336/VA-2020-3-42-52, 27:3, (42-52) Baczkó I, Hornyik T, Brunner M, Koren G and Odening K (2020) Transgenic Rabbit Models in Proarrhythmia Research, Frontiers in Pharmacology, 10.3389/fphar.2020.00853, 11 Saleh M, Gabriels J, Chang D, Soo Kim B, Mansoor A, Mahmood E, Makker P, Ismail H, Goldner B, Willner J, Beldner S, Mitra R, John R, Chinitz J, Skipitaris N, Mountantonakis S and Epstein L (2020) Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection, Circulation: Arrhythmia and Electrophysiology, 13:6, Online publication date: 1-Jun-2020. Panicker G and Karnad D (2020) Mechanisms of drug-induced QT interval prolongation Sex and Cardiac Electrophysiology, 10.1016/B978-0-12-817728-0.00025-5, (283-302), . Gomes J (2020) The Channelopathies and Sudden Death Heart Rhythm Disorders, 10.1007/978-3-030-45066-3_19, (267-289), . Woosley R and Schwartz P (2020) Drug-Induced Long QT Syndrome and Torsades de Pointes Cardiac Repolarization, 10.1007/978-3-030-22672-5_10, (185-200), . Jungbauer C and Maier L (2019) Proarrhythmische Nebenwirkungen von Nicht-AntiarrhythmikaProarrhythmic adverse effects of nonarrhythmic drugs, Herzschrittmachertherapie + Elektrophysiologie, 10.1007/s00399-019-00635-0, 30:3, (262-267), Online publication date: 1-Sep-2019. Vitali Serdoz L, Rittger H, Furlanello F and Bastian D (2019) Quinidine—A legacy within the modern era of antiarrhythmic therapy, Pharmacological Research, 10.1016/j.phrs.2019.04.028, 144, (257-263), Online publication date: 1-Jun-2019. Lester R, Paglialunga S and Johnson I (2019) QT Assessment in Early Drug Development: The Long and the Short of It, International Journal of Molecular Sciences, 10.3390/ijms20061324, 20:6, (1324) Grace A and Matthews G (2019) Quinidine Rebooted, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2019.01.015, 5:3, (383-386), Online publication date: 1-Mar-2019. Huang C (2019) Atrial fibrillation, what exactly do we know? (English version), International Journal of Heart Rhythm, 10.4103/IJHR.IJHR_4_20, 4:2, (43), . Eyal S (2018) The Fever Tree: from Malaria to Neurological Diseases, Toxins, 10.3390/toxins10120491, 10:12, (491) Smulyan H (2018) The Beat Goes On: The Story of Five Ageless Cardiac Drugs, The American Journal of the Medical Sciences, 10.1016/j.amjms.2018.04.011, 356:5, (441-450), Online publication date: 1-Nov-2018. Giudicessi J, Ackerman M and Camilleri M (2018) Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias, Neurogastroenterology & Motility, 10.1111/nmo.13302, 30:6, Online publication date: 1-Jun-2018. Chenoweth J, Hougham A, Colby D, Ford J, Sandhu J, Albertson T and Sutter M (2018) Monitoring the corrected QT in the acute care setting: A comparison of the 12‑lead ECG and bedside monitor, The American Journal of Emergency Medicine, 10.1016/j.ajem.2017.10.012, 36:5, (777-779), Online publication date: 1-May-2018. Postema P (2018) Idiopathic Ventricular Fibrillation and Early Repolarization Channelopathies in Heart Disease, 10.1007/978-3-319-77812-9_11, (257-275), . Huang H, Pugsley M, Fermini B, Curtis M, Koerner J, Accardi M and Authier S (2017) Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative, Journal of Pharmacological and Toxicological Methods, 10.1016/j.vascn.2017.04.002, 87, (11-23), Online publication date: 1-Sep-2017. Turker I, Ai T, Itoh H and Horie M (2017) Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2017.05.001, 176, (48-59), Online publication date: 1-Aug-2017. Osadchii O (2017) Role of abnormal repolarization in the mechanism of cardiac arrhythmia, Acta Physiologica, 10.1111/apha.12902, 220:S712, (1-71), Online publication date: 1-Jul-2017. Camm A (2017) Hopes and disappointments with antiarrhythmic drugs, International Journal of Cardiology, 10.1016/j.ijcard.2017.03.056, 237, (71-74), Online publication date: 1-Jun-2017. Mehrotra D, Fan L, Liu F and Tsai K (2017) Enabling robust assessment of QTc prolongation in early phase clinical trials, Pharmaceutical Statistics, 10.1002/pst.1806, 16:3, (218-227), Online publication date: 1-May-2017. Camm A and Savelieva I (2017) Antiarrhythmic Drug Management of Atrial Fibrillation Cardiac Arrhythmias, Pacing and Sudden Death, 10.1007/978-3-319-58000-5_8, (87-104), . Smith S (2017) Sodium Channel-Blocking Antidysrhythmics Critical Care Toxicology, 10.1007/978-3-319-17900-1_134, (821-841), . Wiśniowska B, Tylutki Z, Wyszogrodzka G and Polak S (2016) Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials, BMC Pharmacology and Toxicology, 10.1186/s40360-016-0053-1, 17:1, Online publication date: 1-Dec-2016. Lee A and Pickham D (2016) Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias, Critical Care Nursing Clinics of North America, 10.1016/j.cnc.2016.04.007, 28:3, (357-371), Online publication date: 1-Sep-2016. McCauley M, Vallabhajosyula S and Darbar D (2016) Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients, Cardiac Electrophysiology Clinics, 10.1016/j.ccep.2016.02.009, 8:2, (481-493), Online publication date: 1-Jun-2016. (2016) Ventricular Tachycardia due to Long QT Syndrome Associated to Non-Cardiac Pharmacological Agents, Journal of Cardiology & Current Research, 10.15406/jccr.2016.05.00176, 5:5 Roden D (2016) Predicting drug‐induced QT prolongation and torsades de pointes, The Journal of Physiology, 10.1113/JP270526, 594:9, (2459-2468), Online publication date: 1-May-2016. Schwartz P and Woosley R (2016) Predicting the Unpredictable, Journal of the American College of Cardiology, 10.1016/j.jacc.2015.12.063, 67:13, (1639-1650), Online publication date: 1-Apr-2016. Barbey J, Connolly M, Beaty B and Krantz M (2015) Man versus Machine: Comparison of Automated and Manual Methodologies for Measuring the QTc Interval: A Prospective Study, Annals of Noninvasive Electrocardiology, 10.1111/anec.12277, 21:1, (82-90), Online publication date: 1-Jan-2016. Havakuk O and Viskin S (2016) A Tale of 2 Diseases, Journal of the American College of Cardiology, 10.1016/j.jacc.2015.10.020, 67:1, (100-108), Online publication date: 1-Jan-2016. Smith S (2016) Sodium Channel-Blocking Antidysrhythmics Critical Care Toxicology, 10.1007/978-3-319-20790-2_134-1, (1-22), . Viskin S, Havakuk O and Schwaber M (2015) Pro-Arrhythmic Effects of Noncardiac Medications, Journal of the American College of Cardiology, 10.1016/j.jacc.2015.09.027, 66:20, (2185-2188), Online publication date: 1-Nov-2015. Vermeer N, Straus S, Mantel‐Teeuwisse A, Hidalgo‐Simon A, Egberts A, Leufkens H and De Bruin M (2015) Drug‐induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab, Clinical Pharmacology & Therapeutics, 10.1002/cpt.207, 98:5, (542-550), Online publication date: 1-Nov-2015. Vicente J, Simlund J, Johannesen L, Sundh F, Florian J, Ugander M, Wagner G, Woosley R and Strauss D (2015) Investigation of potential mechanisms of sex differences in quinidine-induced torsade de pointes risk, Journal of Electrocardiology, 10.1016/j.jelectrocard.2015.03.011, 48:4, (533-538), Online publication date: 1-Jul-2015. Fradley M and Moslehi J (2015) QT Prolongation and Oncology Drug Development, Cardiac Electrophysiology Clinics, 10.1016/j.ccep.2015.03.013, 7:2, (341-355), Online publication date: 1-Jun-2015. Villamañán E, Armada E and Ruano M (2015) Prolongación del intervalo QT inducido por fármacos: ¿conocemos sus riesgos?, Medicina Clínica, 10.1016/j.medcli.2014.01.027, 144:6, (269-274), Online publication date: 1-Mar-2015. Villamañán E, Armada E and Ruano M (2015) Drug-induced QT interval prolongation: Do we know the risks?, Medicina Clínica (English Edition), 10.1016/j.medcle.2014.01.009, 144:6, (269-274), Online publication date: 1-Mar-2015. Christ T, Pecha S and Jost N (2015) Treatment of Atrial Fibrillation and Atrial Flutter Pathophysiology and Pharmacotherapy of Cardiovascular Disease, 10.1007/978-3-319-15961-4_50, (1059-1079), . Gintant G and Valentin J (2015) Drug-Induced Prolongation of the QT Interval: Present and Future Challenges for Drug Discovery Pathophysiology and Pharmacotherapy of Cardiovascular Disease, 10.1007/978-3-319-15961-4_49, (1039-1057), . Leclercq T, Parrel S, Mierdl S, Cottin Y and Girard C (2014) Syndrome du QT long acquis et arrêt cardiorespiratoire post-anesthésie générale. À propos d'un cas et revue de la littérature, Annales Françaises d'Anesthésie et de Réanimation, 10.1016/j.annfar.2014.04.009, 33:6, (421-426), Online publication date: 1-Jun-2014. Crotti L and Schwartz P (2014) Drug-Induced Long QT Syndrome and Exome Sequencing, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.01.030, 63:14, (1438-1440), Online publication date: 1-Apr-2014. Haen E (2014) ArzneimittelinteraktionenDrug-drug interactions, Der Nervenarzt, 10.1007/s00115-013-3935-0, 85:4, (417-426), Online publication date: 1-Apr-2014. Velat I and Čulić V (2014) Circulating magnesium and cardiovascular events, The American Journal of Clinical Nutrition, 10.3945/ajcn.113.077313, 99:3, (647-648), Online publication date: 1-Mar-2014. Hasnain M, Vieweg W, Howland R, Kogut C, Breden Crouse E, Koneru J, Hancox J, Digby G, Baranchuk A, Deshmukh A and Pandurangi A (2014) Quetiapine and the Need for a Thorough QT/QTc Study, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000075, 34:1, (3-6), Online publication date: 1-Feb-2014. Sarganas G, Garbe E, Klimpel A, Hering R, Bronder E and Haverkamp W (2013) Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany, Europace, 10.1093/europace/eut214, 16:1, (101-108), Online publication date: 1-Jan-2014. Brown C and Padmanabhan S (2014) QTc and Sudden Cardiac Death Handbook of Pharmacogenomics and Stratified Medicine, 10.1016/B978-0-12-386882-4.00033-5, (779-806), . Amuzescu B, Istrate B and Musat S (2014) Channelopathies and Heart Disease Cardiac Arrhythmias, 10.1007/978-1-4471-5316-0_9, (95-129), . Mujtaba S, Romero J and Taub C (2013) Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale?, Journal of Cardiovascular Disease Research, 10.1016/j.jcdr.2013.10.001, Online publication date: 1-Nov-2013. Fazio G, Vernuccio F, Lo Re G, Grutta G and Mongiovì M (2013) Role of Bisoprolol in Patients with Long QT Syndrome, Annals of Noninvasive Electrocardiology, 10.1111/anec.12047, 18:5, (467-470), Online publication date: 1-Sep-2013. Brojmohun A, Lou J, Zardkoohi O and Funk M (2013) Protected from Torsades de Pointes? What Psychiatrists Need to Know About Pacemakers and Defibrillators, Psychosomatics, 10.1016/j.psym.2013.02.011, 54:5, (407-417), Online publication date: 1-Sep-2013. Li G, Cheng G, Wu J, Zhou X, Liu P and Sun C (2013) Drug-Induced Long QT Syndrome in Women, Advances in Therapy, 10.1007/s12325-013-0056-x, 30:9, (793-802), Online publication date: 1-Sep-2013. Pickham D (2013) Understanding and Documenting QT Intervals, Critical Care Nurse, 10.4037/ccn2013237, 33:4, (73-75), Online publication date: 1-Aug-2013. Ramirez A, Shaffer C, Delaney J, Sexton D, Levy S, Rieder M, Nickerson D, George A and Roden D (2012) Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes, The Pharmacogenomics Journal, 10.1038/tpj.2012.14, 13:4, (325-329), Online publication date: 1-Aug-2013. Rampe D and Brown A (2013) A history of the role of the hERG channel in cardiac risk assessment, Journal of Pharmacological and Toxicological Methods, 10.1016/j.vascn.2013.03.005, 68:1, (13-22), Online publication date: 1-Jul-2013. Ferri N, Siegl P, Corsini A, Herrmann J, Lerman A and Benghozi R (2013) Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2013.03.005, 138:3, (470-484), Online publication date: 1-Jun-2013. Morley S (2012) Drug-Induced Long QT Syndrome - Clinical and Analytical Aspects for Medical Examiners, Academic Forensic Pathology, 10.23907/2012.036, 2:3, (242-249), Online publication date: 1-Sep-2012. Bauman J (2012) Torsade de Pointes Due to Dronedarone: Déjà Vu?, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1002/j.1875-9114.2012.01140.x, 32:8, (764-766), Online publication date: 1-Aug-2012. Vandenberg J, Perry M, Perrin M, Mann S, Ke Y and Hill A (2012) hERG K + Channels: Structure, Function, and Clinical Significance , Physiological Reviews, 10.1152/physrev.00036.2011, 92:3, (1393-1478), Online publication date: 1-Jul-2012. Antzelevitch C and Sicouri S (2012) Mechanisms Underlying Arrhythmogenesis in Long QT Syndrome, Cardiac Electrophysiology Clinics, 10.1016/j.ccep.2011.12.001, 4:1, (17-27), Online publication date: 1-Mar-2012. Roden D, Kannankeril P, Kääb S and Darbar D (2012) Genomics of the Drug-Induced Long-QT Syndrome Principles of Pharmacogenetics and Pharmacogenomics, 10.1017/CBO9781139051194.016, (136-144) Kallergis E, Goudis C, Simantirakis E, Kochiadakis G and Vardas P (2012) Mechanisms, Risk Factors, and Management of Acquired Long QT Syndrome: A Comprehensive Review, The Scientific World Journal, 10.1100/2012/212178, 2012, (1-8), . Gillis A (2012) Proarrhythmia Syndromes Electrophysiological Disorders of the Heart, 10.1016/B978-1-4377-0285-9.00054-5, (771-782), . Farid T, Nair K, Massé S, Azam M, Maguy A, Lai P, Umapathy K, Dorian P, Chauhan V, Varró A, Al-Hesayen A, Waxman M, Nattel S and Nanthakumar K (2011) Role of KATP Channels in the Maintenance of Ventricular Fibrillation in Cardiomyopathic Human Hearts, Circulation Research, 109:11, (1309-1318), Online publication date: 11-Nov-2011. Hreiche R, Plante I, Drolet B, Morissette P and Turgeon J (2011) Lengthening of Cardiac Repolarization in Isolated Guinea Pigs Hearts by Sequential or Concomitant Administration of Two IKr Blockers, Journal of Pharmaceutical Sciences, 10.1002/jps.22437, 100:6, (2469-2481), Online publication date: 1-Jun-2011. Subbiah R and Campbell T (2011) Antiarrhythmic drugs Coronary Care Manual, 10.1016/B978-0-7295-3927-2.10030-2, (224-241), . Kannankeril P, Roden D, Darbar D and Sibley D (2010) Drug-Induced Long QT Syndrome, Pharmacological Reviews, 10.1124/pr.110.003723, 62:4, (760-781), Online publication date: 1-Dec-2010. Singh M, Arora R and Jawad E (2010) HIV Protease Inhibitors Induced Prolongation of the QT Interval: Electrophysiology and Clinical Implications, American Journal of Therapeutics, 10.1097/MJT.0b013e3181ad3437, 17:6, (e193-e201), Online publication date: 1-Nov-2010. Balijepalli S, Anderson C, Lin E and January C (2010) Rescue of Mutated Cardiac Ion Channels in Inherited Arrhythmia Syndromes, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e3181dab014, 56:2, (113-122), Online publication date: 1-Aug-2010. Li E, Esterly J, Pohl S, Scott S and McBride B (2012) Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1592/phco.30.7.684, 30:7, (684-701), Online publication date: 1-Jul-2010. Lazzara R (2010) The Right Stuff in the Right Place-The Quest for Atrial Selective Antiarrhythmic Agents, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e3181e5d343, 56:1, (78-79), Online publication date: 1-Jul-2010. Virginia Soldovieri M and Taglialatela M (2010) Cellular Mechanisms, Molecular Targets, and Structure–Function Relationships in Drug‐Induced Arrhythmias: Antihistamines, Psychoactive Drugs, and Antimicrobial Agents Cardiotoxicity of Non‐Cardiovascular Drugs, 10.1002/9780470660379.ch3, (47-96), Online publication date: 16-Apr-2010. Farkas A and Nattel S (2010) Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice, Drugs, 10.2165/11535230-000000000-00000, 70:5, (573-603), Online publication date: 1-Mar-2010. Malik M (2010) Facts, fancies and follies of drug‐induced QT/QTc interval shortening, British Journal of Pharmacology, 10.1111/j.1476-5381.2009.00554.x, 159:1, (70-76), Online publication date: 1-Jan-2010. Salvi V, Karnad D, Panicker G and Kothari S (2010) Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development, British Journal of Pharmacology, 10.1111/j.1476-5381.2009.00427.x, 159:1, (34-48), Online publication date: 1-Jan-2010. Bialecki R, Lainee P and Valentin J (2010) Iatrogenic QT Prolongation Comprehensive Toxicology, 10.1016/B978-0-08-046884-6.00718-1, (365-402), . Viskin S, Rosso R, Márquez M and Antzelevitch C (2009) The acquired Brugada syndrome and the paradox of choice, Heart Rhythm, 10.1016/j.hrthm.2009.07.033, 6:9, (1342-1344), Online publication date: 1-Sep-2009. Raghu K, Singh R, Prathapan A and Yadav G (2009) Modulation of haloperidol induced electrophysiological alterations on cardiac action potential by various risk factors and gender difference, Chemico-Biological Interactions, 10.1016/j.cbi.2009.05.002, 180:3, (454-459), Online publication date: 1-Aug-2009. Killeen M (2009) Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry, Drug Discovery Today, 10.1016/j.drudis.2009.03.004, 14:11-12, (589-597), Online publication date: 1-Jun-2009. Schwaab B, Katalinic A, Böge U, Loh J, Blank P, Kölzow T, Poppe D and Bonnemeier H (2009) Quinidine for Pharmacological Cardioversion of Atrial Fibrillation: A Retrospective Analysis in 501 Consecutive Patients, Annals of Noninvasive Electrocardiology, 10.1111/j.1542-474X.2009.00287.x, 14:2, (128-136), Online publication date: 1-Apr-2009. Yang F, Hanon S, Lam P and Schweitzer P (2009) Quinidine Revisited, The American Journal of Medicine, 10.1016/j.amjmed.2008.11.019, 122:4, (317-321), Online publication date: 1-Apr-2009. Hreiche R, Morissette P, Zakrzewski-Jakubiak H and Turgeon J (2009) Gender-related Differences in Drug-induced Prolongation of Cardiac Repolarization in Prepubertal Guinea Pigs, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248408331018, 14:1, (28-37), Online publication date: 1-Mar-2009. Perrin M, Subbiah R, Vandenberg J and Hill A (2008) Human ether-a-go-go related gene (hERG) K+ channels: Function and dysfunction, Progress in Biophysics and Molecular Biology, 10.1016/j.pbiomolbio.2008.10.006, 98:2-3, (137-148), Online publication date: 1-Oct-2008. Pickham D and Drew B (2008) QT/QTc Interval Monitoring in the Emergency Department, Journal of Emergency Nursing, 10.1016/j.jen.2007.10.016, 34:5, (428-434), Online publication date: 1-Oct-2008. Roden D (2009) Cellular basis of drug‐induced torsades de pointes, British Journal of Pharmacology, 10.1038/bjp.2008.238, 154:7, (1502-1507), Online publication date: 1-Aug-2008. Vik T, Pollard C and Sager P (2008) Early clinical development: Evaluation of drug-induced torsades de pointes risk, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.05.006, 119:2, (210-214), Online publication date: 1-Aug-2008. PRYSTOWSKY E (2008) The History of Atrial Fibrillation: The Last 100 Years, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2008.01184.x, 19:6, (575-582), Online publication date: 1-Jun-2008. Batchvarov V and Camm A (2008) Prolongation of the QT interval and ventricular arrhythmias: Some early observations, Heart Rhythm, 10.1016/j.hrthm.2008.02.022, 5:6, (892-894), Online publication date: 1-Jun-2008. Hreiche R, Morissette P and Turgeon J (2008) Drug-induced long QT syndrome in women: Review of current evidence and remaining gaps, Gender Medicine, 10.1016/j.genm.2008.05.005, 5:2, (124-135), Online publication date: 1-Jun-2008. Kannankeril P (2008) Understanding drug-induced torsades de pointes: a genetic stance, Expert Opinion on Drug Safety, 10.1517/14740338.7.3.231, 7:3, (231-239), Online publication date: 1-May-2008. Soldovieri M, Miceli F and Taglialatela M (2008) Cardiotoxic Effects of Antihistamines: From Basics to Clinics (…and Back), Chemical Research in Toxicology, 10.1021/tx800020c, 21:5, (997-1004), Online publication date: 1-May-2008. Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchie M and Roden D (2008) Persistent Atrial Fibrillation Is Associated With Reduced Risk of Torsades de Pointes in Patients With Drug-Induced Long QT Syndrome, Journal of the American College of Cardiology, 10.1016/j.jacc.2007.09.066, 51:8, (836-842), Online publication date: 1-Feb-2008. (2008) Torsade de Pointes, Ventricular Fibrillation, and Differential Diagnosis of Wide QRS Tachycardias Chou's Electrocardiography in Clinical Practice, 10.1016/B978-141603774-3.10018-8, (440-455), . (2008) Ventricular Arrhythmias Chou's Electrocardiography in Clinical Practice, 10.1016/B978-141603774-3.10017-6, (405-439), . Hiraoka M Mechanisms of Drug-Induced Cardiac Toxicity Electrical Diseases of the Heart, 10.1007/978-1-84628-854-8_49, (691-704) Gupta A, Lawrence A, Krishnan K, Kavinsky C and Trohman R (2007) Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes, American Heart Journal, 10.1016/j.ahj.2007.01.040, 153:6, (891-899), Online publication date: 1-Jun-2007. GUO D, ZHAO X, WU Y, LIU T, KOWEY P and YAN G (2007) L‐Type Calcium Current Reactivation Contributes to Arrhythmogenesis Associated with Action Potential Triangulation, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2006.00698.x, 18:2, (196-203), Online publication date: 1-Feb-2007. Shah R (2007) Cardiac Repolarisation and Drug Regulation, Drug Safety, 10.2165/00002018-200730120-00003, 30:12, (1093-1110), . Stokoe K, Thomas G, Goddard C, Colledge W, Grace A and Huang C (2006) Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a +/Δ murine hearts modelling long QT syndrom
Referência(s)